InsidersTradesSigma
Follow the CStone Pharmaceuticals - B stock price and the full directors' dealings record of the company, a publicly traded company based in Hong Kong. Shares are listed on the HK market, under the authority of HKEX. Operating in the Health Care sector, CStone Pharmaceuticals - B has published 24 insider filings. Market capitalisation: €9.3bn. The latest transaction was reported on 10 September 2026 (Other). Among the most active insiders: Yang Jianxin. All data is free.
24
Insider Decl.
n/a
Thresholds
€1m
14 ops.
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate CStone Pharmaceuticals - B Strong Buy (bullish), based on 4 analysts. Average price target: HK$14.34.
24Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 26,697 of 29,064 companies
19.8
score / 100
Value25
Quality15
FCF yld-3.5%
Earn yld-4.7%
EV/EBITDA·
ROE-52%
Gross mgn19%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 10 September 2026
Declarations24 total
208,500 sharesShareXHKGHKEX:DA20260909E00496
63,000 sharesShareXHKGHKEX:DA20260707E00463
331,000 shares@ HK$4.64230.018% mcap30.2% of flowShareXHKGHKEX:DA20260701E00109
448,875 sharesShareXHKGHKEX:DA20260701E00108
11,270,000 sharesShareXHKGHKEX:DA20260625E00306
56,500 shares@ HK$4.660.0031% mcap7.3% of flowShareXHKGHKEX:DA20260615E00264
200,000 shares@ HK$4.570.011% mcap25.4% of flowShareXHKGHKEX:DA20260612E00338
400,000 shares@ HK$4.47890.021% mcap100.0% of flowShareXHKGHKEX:DA20260610E00351
145,000 shares@ HK$4.25930.0073% mcap17.2% of flowShareXHKGHKEX:DA20260610E00353
200,000 shares@ HK$4.2550.010% mcap47.4% of flowShareXHKGHKEX:DA20260609E00345
200,000 shares@ HK$4.7550.011% mcap52.6% of flowShareXHKGHKEX:DA20260605E00376
105,000 shares@ HK$4.87760.0059% mcap9.0% of flowShareXHKGHKEX:DA20260603E00307
24 of 24 declarations
关于 CStone Pharmaceuticals - B
基石药业是一家生物制药公司，专注于开发创新的癌症治疗方法。该公司在香港证券交易所上市，股票代码为 XHKG。